Epigenetic regulation of nitric oxide synthase 2, inducible (Nos2) by NLRC4 inflammasomes involves PARP1 cleavage
Nitric oxide synthase 2, inducible ( Nos2 ) expression is necessary for the microbicidal activity of macrophages. However, NOS2 over-activation causes multiple inflammatory disorders, suggesting a tight gene regulation is necessary. Using cytosolic flagellin as a model for inflammasome-dependent NOS...
Gespeichert in:
Veröffentlicht in: | Scientific reports 2017-02, Vol.7 (1), p.41686-41686, Article 41686 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Nitric oxide synthase 2, inducible (
Nos2
) expression is necessary for the microbicidal activity of macrophages. However, NOS2 over-activation causes multiple inflammatory disorders, suggesting a tight gene regulation is necessary. Using cytosolic flagellin as a model for inflammasome-dependent NOS2 activation, we discovered a surprising new role for NLRC4/caspase-1 axis in regulating chromatin accessibility of the
Nos2
promoter. We found that activation of two independent mechanisms is necessary for NOS2 expression by cytosolic flagellin: caspase-1 and NF-κB activation. NF-κB activation was necessary, but not sufficient, for NOS2 expression. Conversely, caspase-1 was necessary for NOS2 expression, but dispensable for NF-κB activation, indicating that this protease acts downstream NF-κB activation. We demonstrated that epigenetic regulation of
Nos2
by caspase-1 involves cleavage of the chromatin regulator PARP1 (also known as ARTD1) and chromatin accessibility of the NF-κB binding sites located at the
Nos2
promoter. Remarkably, caspase-1-mediated
Nos2
transcription and NO production contribute to the resistance of macrophages to
Salmonella typhimurium
infection. Our results uncover the molecular mechanism behind the constricted regulation of
Nos2
expression and open new therapeutic opportunities based on epigenetic activities of caspase-1 against infectious and inflammatory diseases. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/srep41686 |